Literature DB >> 9479657

Code Stroke: rapid transport, triage and treatment using rt-PA therapy. The NINDS rt-PA Stroke Study Group.

K Rapp1, P Bratina, C Barch, J Braimah, S Daley, R Donnarumma, G Kongable, S Sailor, J Spilker.   

Abstract

With the approval of rt-PA therapy for ischemic stroke, stroke care has acutely transitioned from focusing on rehabilitative services to emergency services. This treatment, which must be initiated within the first three hours after the onset of stroke symptoms, requires reorganization of current management approaches. Developing a Code Stroke Team facilitates this process and helps to identify potential thrombolysis candidates. A pathway to deliver rapid care begins with 911 notification and transport, emergency department triage and procedures, and moves through the initiation of thrombolytic therapy. We call this pathway "Code Stroke".

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9479657     DOI: 10.1097/01376517-199712000-00005

Source DB:  PubMed          Journal:  J Neurosci Nurs        ISSN: 0888-0395            Impact factor:   1.230


  3 in total

1.  Building a "brain attack" team to administer thrombolytic therapy for acute ischemic stroke.

Authors:  M D Hill; P A Barber; A M Demchuk; R J Sevick; N J Newcommon; T Green; A M Buchan
Journal:  CMAJ       Date:  2000-05-30       Impact factor: 8.262

2.  Advancement of door-to-needle times in acute stroke treatment after repetitive process analysis: never give up!

Authors:  Johanna Ernst; Kai F Storch; Anh Thu Tran; Maria M Gabriel; Andrei Leotescu; Anna-Lena Boeck; Meret K Huber; Omar Abu-Fares; Paul Bronzlik; Friedrich Götz; Hans Worthmann; Ramona Schuppner; Gerrit M Grosse; Karin Weissenborn
Journal:  Ther Adv Neurol Disord       Date:  2022-09-15       Impact factor: 6.430

3.  Determining intravenous rt-PA eligibility in the Emergency Department.

Authors:  Amy C Mecozzi; Devin L Brown; Lynda D Lisabeth; William G Barsan; Robert Silbergleit; Susan L Hickenbottom; Phillip A Scott; Lewis B Morgenstern
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.532

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.